FDA's cGMPs for the 21st Century Initiative

Instructor: Betty Jones
Product ID: 700156
Training Level: Intermediate

recorded version

1x Person - Unlimited viewing for 6 Months
(For multiple locations contact Customer Care)
Recorded Link and Ref. material will be available in My CO Section

Training CD

One CD is for usage in one location only.
(For multiple locations contact Customer Care)
CD and Ref. material will be shipped within 15 business days

Customer Care

Fax: +1-650-963-2556


Read Frequently Asked Questions

This presentation will provide and insiders view FDA’s path to restructuring its regulatory oversight of manufacturing quality that is based on quality systems and risk management approaches


In 2002, FDA announced a significant new initiative, Current Good Manufacturing Practices (cGMPs) for the 21st Century intended to modernize FDA’s regulation of pharmaceutical quality and established a new regulatory framework for manufacturing.

Implementation of the envisioned new framework and its elements require the use of risk-based and science-based approaches for regulatory decision-making throughout the entire life-cycle of the product.

Areas Covered in the seminar:
  • FDA’s cGMPs for the 21st Century Initiative
  • Background and Scope
  • Fundamental Principle
  • Objectives and Guiding Principles
  • Concepts of Quality Systems and cGMPs
  • cGMP and Quality Systems Comparisons
  • cGMP Compliance
  • Questions
Who Will Benefit:
This webinar will provide valuable assistance to pharmaceutical, device and biologics regulated companies in or transitioning into a cGMP environment. It is also useful as a refresher for companies that wish to stay current with cGMP regulations and FDA’s expectations. The employees who will benefit include:
  • Management
  • Quality Units (Quality Control/Quality Assurance)
  • Production Personnel
  • Internal Auditors
  • Quality Systems Personnel
  • Consultants

Instructor Profile
Betty L. Jones, MPH, is Managing Director/Founder of Comprehensive Compliance Solutions (CCS), a consulting firm specializing in all aspects of regulatory compliance and training to firms that manufacture and market FDA regulated products. Ms. Jones is the former Deputy Director of the Office of Compliance, CDER and a recognized expert in applying and interpreting FDA’s statutes, codes, regulations and standards. She has over 33 years of experience with the FDA directing regulatory and compliance activities in three of FDA’s six components and has experience as a field investigator, a compliance officer, Branch chief and Acting Office Director.

Follow us :
ComplianceOnline Banking Summit 2016 | Risk Management and Data Security - 80390SEM
21 CFR Part 11 Compliance for SaaS/Cloud Applications - 80202SEM

Product Reviews

This product hasn't received any reviews yet. Be the first to review this product! Write review

Best Sellers
You Recently Viewed